For example, MALAT1 leads to the epithelial-to-mesenchymal transition program through a phosphatidylinositide-3 kinase-AKT pathway in breast cancer, and thus MALAT1 is significantly downregulated in breast cancer tissues and cell lines (Zhao et al., 2014). This evidence concerns the gene MALAT1 and breast carcinoma.